Alan P Timmins

Title: Innovations of Alan P Timmins

Introduction

Alan P Timmins is a notable inventor based in Sherwood, Oregon, who has made significant contributions to the field of biotechnology. He holds a total of four patents, showcasing his innovative approach to addressing medical challenges, particularly in muscle atrophy.

Latest Patents

One of his latest patents is an antisense composition and method for treating muscle atrophy. This invention involves a method and compound designed to treat skeletal muscle mass deficiency in human subjects. The composition consists of an oligomer of morpholino subunits linked by phosphorus-containing intersubunit linkages. It contains between 10-40 nucleotide bases and has a base sequence effective to hybridize to an expression-sensitive region of processed or preprocessed human myostatin RNA transcript. The compound is capable of uptake by target muscle cells in the subject. The method involves administering the compound in a specific amount and dosage schedule to reduce serum myostatin levels in patients, ideally bringing these levels within a range typical for healthy individuals.

Career Highlights

Throughout his career, Alan has worked with prominent companies in the biotechnology sector, including Sarepta Therapeutics, Inc. and Avi Biopharma, Inc. His work in these organizations has contributed to advancements in therapeutic solutions for muscle-related conditions.

Collaborations

Alan has collaborated with notable professionals in his field, including Patrick L Iversen and Dwight D Weller. These collaborations have likely enhanced the development and implementation of his innovative ideas.

Conclusion

Alan P Timmins is a distinguished inventor whose work in biotechnology has the potential to significantly impact the treatment of muscle atrophy. His innovative patents and collaborations reflect his commitment to advancing medical science.